imugene (asx:imu) | jmm & éthica capital innovation interview \ may 2024
Published 4 months ago • 983 plays • Length 5:04Download video MP4
Download video MP3
Similar videos
-
15:06
imugene (asx:imu) | jmm & éthica capital innovation & investment insights | may 2024
-
7:40
imugene limited (asx: imu) emergence 2024: presentation by leslie chong, managing director and ceo
-
4:51
'the why' | imugene, developing cancer immunotherapies asx: imu
-
4:14
imugene (asx:imu) doses first patient in iv arm of phase 1 oncarlytics trial targeting solid cancers
-
1:43
imugene’s asx imu azer cel car t therapy trial shows encouraging results in blood cancer
-
20:44
asx small and mid-cap conference march 2024 | imugene ltd (asx:imu)
-
1:00
imugene (asx: imu) promo | behind the scenes with host laurence fishburne
-
3:51
imugene limited (asx:imu) three complete responses in azer-cel phase 1b trial
-
4:14
imugene doses first patient in phase 1 oncarlytics iv infusion combination trial
-
7:17
imugene ceo and coo speak with juststocks video after promising results in blood cancer trial
-
4:28
imugene with proactive at asx small and mid cap conference
-
26:23
imugene (asx:imu) presentation, nwr virtual healthcare conference
-
4:54
imugene reports promising results in phase 1b trial for azer-cel in dlbcl
-
4:53
imugene (asx: imu) featured on fox business 'trending today' - trailblazers in biotech
-
20:37
imugene (asx: imu) – the ‘holy grail’ of cancer treatment…?! | asx ceo interview 🚀📈
-
5:30
imugene releases final data from phase 2 her vaxx study
-
4:49
imugene her-vaxx video asx: imu | an emerging leader in cancer immuno-oncology
-
26:23
imugene (asx: imu) presentation, nwr virtual healthcare conference
-
4:12
imugene's ceo interviewed on ausbiz detailing a clinical trial deal with merck germany and pfizer.
-
20:57
imugene (asx: imu) - discussing imu's 2022 biotech opportunity